| Literature DB >> 33343485 |
Annina Fahr1,2,3, Jeffrey W Keller1,2,4, Hubertus J A van Hedel1,2.
Abstract
Background: Impaired selective voluntary motor control is defined as "the reduced ability to isolate the activation of muscles in response to demands of a voluntary posture or movement." It is a negative motor sign of an upper motor neuron lesion. Objective: This paper reviews interventions that may improve selective motor control in children and youths with spastic cerebral palsy. The aim was to systematically evaluate the methodological quality and formulate the level of evidence from controlled studies.Entities:
Keywords: best evidence synthesis; cerebral palsy; involuntary movements; pediatric neurorehabilitation; selective voluntary motor control
Year: 2020 PMID: 33343485 PMCID: PMC7746811 DOI: 10.3389/fneur.2020.572038
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart showing the process of study selection.
Overview of the included studies.
ADL, activities of daily living; CP, cerebral palsy; GMFCS, gross motor function classification system; h, hours; MACS, manual ability classification system; RCT, randomized controlled trial; ROM, range of motion; SD, standard deviation; sig, significant.
.
.
Assessments measuring SVMC.
| Melbourne assessment— sub-skill range of movement | ( |
| Pediatric arm function test | ( |
| Quality of upper extremity skills test—domain dissociated movement | ( |
| Selective control assessment of the lower extremity | ( |
| Selective motor control assessment of ankle dorsiflexion | ( |
| Shriners hospital upper extremity evaluation—dynamic positional analysis | ( |
| Trunk control measurement scale—selective movement control | ( |
| Trunk displacement during reaching movement | ( |
| Video-observation aarts and aarts module determine Developmental disregard—capacity score | ( |
These assessments measure SVMC on the level of body function. Although children are sometimes observed during activities in these assessments, the test criteria still rate body functions.
Levels of evidence and methodological quality rating of included studies in accordance with AACPDM guidelines.
| Christmas et al. ( | II | Strong−7/7 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Gordon et al. ( | II | Strong−7/7 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Gelkop et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Aarts et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Choudhary et al. ( | II | Strong−6/7 | Yes | No | Yes | Yes | Yes | Yes | Yes |
| DeLuca et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| DeLuca et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Facchin et al. ( | II | Moderate−5/7 | Yes | No | Yes | Yes | No | Yes | Yes |
| Taub et al. ( | II | Moderate−4/7 | Yes | No | Yes | Yes | No | Yes | No |
| Gilliaux et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| El-Shamy et al. ( | II | Moderate−5/7 | Yes | No | Yes | Yes | No | Yes | Yes |
| Chen et al. ( | II | Moderate−4/7 | Yes | Yes | Yes | No | No | No | Yes |
| Pool et al. ( | II | Strong−6/7 | Yes | Yes | Yes | No | Yes | Yes | Yes |
| Acar et al. ( | II | Moderate−4/7 | Yes | No | Yes | No | No | Yes | Yes |
| Damiano et al. ( | II | Moderate−5/7 | Yes | Yes | Yes | No | Yes | Yes | No |
| Ben-Pazi et al. ( | II | Moderate−4/7 | Yes | No | Yes | Yes | No | Yes | No |
| Bruchez et al. ( | II | Strong−7/7 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Kara et al. ( | II | Strong−7/7 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Gygax et al. ( | II | Moderate−5/7 | Yes | No | Yes | Yes | No | Yes | Yes |
| Kirkpatrick et al. ( | II | Strong−7/7 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Kusumoto et al. ( | II | Strong−6/7 | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Numanoglu Akbas et al. ( | II | Moderate−5/7 | Yes | No | Yes | Yes | No | Yes | Yes |
| Schneiberg et al. ( | I | Moderate−7/14 | |||||||
| No | Yes | Yes | Yes | No/No | Yes | No | |||
| No/No | No | Yes | Yes | No | Yes | No | |||
The levels of evidence represent the ability of the study design to establish causality between the intervention and the outcome from I—most definitive to V—only suggesting the possibility. AACPDM, American Academy for Cerebral Palsy and Developmental Medicine.
The color code represents the groups of similar types of interventions. Red colours stand for constraint-based therapies, blue colors for rehabilitation technologies and green colors for other approaches.
Cochrane risk of bias assessment of included studies.
| Christmas et al. ( | Low risk | High risk | Low risk | Low risk | Unclear | Low risk | Low risk |
| Gordon et al. ( | Low risk | Low risk | Low risk | Low risk | Unclear | Unclear | Low risk |
| Gelkop et al. ( | Low risk | Low risk | Low risk | Low risk | High risk | Unclear | Low risk |
| Aarts et al. ( | Low risk | Low risk | Low risk | Low risk | Unclear | Unclear | Low risk |
| Choudhary et al. ( | Low risk | High risk | High risk | Low risk | Low risk | High risk | Low risk |
| DeLuca et al. ( | Unclear | Unclear | Low risk | Low risk | Low risk | Unclear | Low risk |
| DeLuca et al. ( | Unclear | Unclear | Low risk | Low risk | Unclear | Unclear | Low risk |
| Facchin et al. ( | Unclear | Unclear | Low risk | Low risk | Unclear | Low risk | High risk |
| Taub et al. ( | Unclear | High risk | Low risk | Low risk | Unclear | Unclear | High risk |
| Schneiberg et al. ( | Unclear | Low risk | Low risk | High risk | Unclear | Unclear | Low risk |
| Gilliaux et al. ( | Low risk | Low risk | Low risk | Low risk | Unclear | Low risk | Low risk |
| El-Shamy et al. ( | Low risk | Unclear | Low risk | Low risk | Unclear | Unclear | Low risk |
| Chen et al. ( | Low risk | Unclear | Low risk | High risk | Unclear | Low risk | High risk |
| Pool et al. ( | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk |
| Acar et al. ( | Unclear | Unclear | Low risk | Unclear | Unclear | Unclear | Low risk |
| Damiano et al. ( | Unclear | High risk | Low risk | High risk | Low risk | High risk | High risk |
| Ben-Pazi et al. ( | Low risk | High risk | Low risk | Low risk | Low risk | High risk | High risk |
| Bruchez et al. ( | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kara et al. ( | Low risk | Low risk | Low risk | Low risk | Unclear | High risk | Low risk |
| Gygax et al. ( | Unclear | Unclear | Low risk | Low risk | Unclear | Unclear | Low risk |
| Kirkpatrick et al. ( | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk |
| Kusumoto et al. ( | Low risk | Unclear | Low risk | Low risk | Unclear | Unclear | Low risk |
| Numanoglu Akbas et al. ( | Low risk | Low risk | Low risk | Low risk | Unclear | High risk | Low risk |
Detailed explanation of the seven domains of potential sources of bias are described in the risk of bias assessment of the Cochrane Collaboration (.
The color code represents the groups of similar types of interventions. Red colours stand for constraint-based therapies, blue colors for rehabilitation technologies and green colors for other approaches.
Summary of evidence and best evidence synthesis according to van Tulder et al. (28) of controlled group design studies with moderate or strong methodological quality.
– no effect, + positive effect, *two outcomes, NA, information not available.
Overall level of evidence from best evidence synthesis (.
The color code represents the groups of similar types of interventions. Red colours stand for constraint-based therapies, blue colors for rehabilitation technologies and green colors for other approaches.